Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 USD | +2.19% | -56.94% | -34.93% |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Apr. 23 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 1M | Sales 2025 * | 31.33M | Capitalization | 89.18M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -53M | EV / Sales 2024 * | 89.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.85 x |
P/E ratio 2024 * |
-1.53
x | P/E ratio 2025 * |
-1.72
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
Latest transcript on Abeona Therapeutics Inc.
1 day | +2.19% | ||
1 week | -56.94% | ||
Current month | -55.03% | ||
1 month | -55.71% | ||
3 months | -30.49% | ||
6 months | -15.10% | ||
Current year | -34.93% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.26 | +2.19% | 1,210,920 |
24-04-25 | 3.19 | +0.63% | 1,104,119 |
24-04-24 | 3.17 | -7.04% | 2,219,367 |
24-04-23 | 3.41 | -53.67% | 5,512,776 |
24-04-22 | 7.36 | -2.77% | 1,028,038 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.93% | 89.18M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABEO Stock